NO976112D0 - 1,6-disubstituted isochromes for the treatment of migraine - Google Patents
1,6-disubstituted isochromes for the treatment of migraineInfo
- Publication number
- NO976112D0 NO976112D0 NO976112A NO976112A NO976112D0 NO 976112 D0 NO976112 D0 NO 976112D0 NO 976112 A NO976112 A NO 976112A NO 976112 A NO976112 A NO 976112A NO 976112 D0 NO976112 D0 NO 976112D0
- Authority
- NO
- Norway
- Prior art keywords
- isochromes
- migraine
- disubstituted
- treatment
- disubstituted isochromes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74195P | 1995-06-30 | 1995-06-30 | |
| US1123496P | 1996-02-06 | 1996-02-06 | |
| PCT/US1996/008681 WO1997002259A1 (en) | 1995-06-30 | 1996-06-07 | 1,6-disubstituted isochromans for treatment of migraine headaches |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO976112D0 true NO976112D0 (en) | 1997-12-29 |
| NO976112L NO976112L (en) | 1998-03-02 |
Family
ID=26668092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO976112A NO976112L (en) | 1995-06-30 | 1997-12-29 | 1,6-disubstituted isochromes for the treatment of migraine |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0836599A1 (en) |
| JP (1) | JPH11509532A (en) |
| AU (1) | AU6252296A (en) |
| BR (1) | BR9609631A (en) |
| CA (1) | CA2225282A1 (en) |
| CZ (1) | CZ418597A3 (en) |
| FI (1) | FI974640A0 (en) |
| MX (1) | MX9710260A (en) |
| NO (1) | NO976112L (en) |
| PL (1) | PL324319A1 (en) |
| SK (1) | SK164297A3 (en) |
| WO (1) | WO1997002259A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2370270A (en) * | 2000-12-20 | 2002-06-26 | Lilly Co Eli | Pharmaceutical compounds |
| US7335660B2 (en) | 2001-12-19 | 2008-02-26 | Eli Lilly And Company | Isochroman compounds for treatment of CNS disorders |
| GB0130339D0 (en) * | 2001-12-19 | 2002-02-06 | Lilly Co Eli | Isochroman compounds |
| US7110576B2 (en) | 2002-12-30 | 2006-09-19 | Pitney Bowes Inc. | System and method for authenticating a mailpiece sender |
| BRPI0510642A (en) | 2004-05-05 | 2007-11-20 | Hoffmann La Roche | arylsulfonyl benzodioxanes useful for modulating 5-ht6 receptor, 5ht2a receptor or both |
| WO2006066756A1 (en) | 2004-12-21 | 2006-06-29 | F. Hoffmann-La Roche Ag | Chroman derivatives and uses thereof in the treatment of cns disorders |
| SI1831159T1 (en) | 2004-12-21 | 2010-04-30 | Hoffmann La Roche | Tetralin and indane derivatives and uses thereof |
| WO2006066748A1 (en) | 2004-12-21 | 2006-06-29 | F. Hoffmann-La Roche Ag | Tetralin and indane derivatives and uses thereof as 5-ht antagonists |
| DE602005017663D1 (en) | 2004-12-21 | 2009-12-24 | Hoffmann La Roche | TETRALINE AND INDANDERIVATES AND APPLICATIONS THEREOF |
| CA2592001A1 (en) | 2004-12-21 | 2006-06-29 | F. Hoffmann-La Roche Ag | Chroman derivatives and their use as 5-ht receptor ligands |
| BRPI0618206A2 (en) | 2005-11-03 | 2011-08-23 | Hoffmann La Roche | chromosyl arylsulfonyl as 5-ht6 inhibitors as well as pharmaceutical composition, use and process for producing them |
| MX2008015843A (en) | 2006-06-20 | 2009-01-09 | Hoffmann La Roche | Tetralin and indane derivatives and uses thereof. |
| CA2655524A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffman-La Roche Ag | Arylsulfonamidyl tetralin derivatives and uses thereof |
| EP2041079A1 (en) | 2006-06-20 | 2009-04-01 | F. Hoffmann-Roche AG | Arylsulfonyl naphthalene derivatives and uses thereof |
| EP2404897A4 (en) * | 2009-03-05 | 2014-02-26 | Sumitomo Chemical Co | Method for producing halogen-substituted benzene dimethanol |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1552004A (en) * | 1976-05-26 | 1979-09-05 | Takeda Chemical Industries Ltd | Isochroman derivatives |
| ES2133714T3 (en) * | 1993-12-28 | 1999-09-16 | Upjohn Co | HETERO-CYCLE COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS. |
-
1996
- 1996-06-07 CZ CZ974185A patent/CZ418597A3/en unknown
- 1996-06-07 MX MX9710260A patent/MX9710260A/en unknown
- 1996-06-07 PL PL96324319A patent/PL324319A1/en unknown
- 1996-06-07 AU AU62522/96A patent/AU6252296A/en not_active Abandoned
- 1996-06-07 BR BR9609631A patent/BR9609631A/en not_active Application Discontinuation
- 1996-06-07 CA CA002225282A patent/CA2225282A1/en not_active Abandoned
- 1996-06-07 JP JP9505135A patent/JPH11509532A/en active Pending
- 1996-06-07 WO PCT/US1996/008681 patent/WO1997002259A1/en not_active Application Discontinuation
- 1996-06-07 SK SK1642-97A patent/SK164297A3/en unknown
- 1996-06-07 EP EP96921264A patent/EP0836599A1/en not_active Withdrawn
-
1997
- 1997-12-29 NO NO976112A patent/NO976112L/en unknown
- 1997-12-30 FI FI974640A patent/FI974640A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11509532A (en) | 1999-08-24 |
| PL324319A1 (en) | 1998-05-25 |
| SK164297A3 (en) | 1998-09-09 |
| CA2225282A1 (en) | 1997-01-23 |
| MX9710260A (en) | 1998-03-29 |
| NO976112L (en) | 1998-03-02 |
| BR9609631A (en) | 1999-03-02 |
| CZ418597A3 (en) | 1998-06-17 |
| FI974640A (en) | 1997-12-30 |
| WO1997002259A1 (en) | 1997-01-23 |
| AU6252296A (en) | 1997-02-05 |
| FI974640A0 (en) | 1997-12-30 |
| EP0836599A1 (en) | 1998-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO981800D0 (en) | Process for the preparation of 1,1,1,3,3-pentafluoropentane | |
| NO961483D0 (en) | Process for the treatment of oily formation | |
| NO976112D0 (en) | 1,6-disubstituted isochromes for the treatment of migraine | |
| ITTO940748A0 (en) | PROSTHETIC CONDUIT PARTICULARLY FOR THE TREATMENT OF CARDIOVASCULAR DISEASES. | |
| IL135648A0 (en) | Novel 3, 6-hemiketals from the class of 9a-azalides | |
| IT1292552B1 (en) | DEVICE FOR THE APPLICATION OF COATINGS. | |
| HK1017684A1 (en) | Novel substituted 4-(1h-benzimidazol-2-yl)(1,4)diazepanes useful for the treatment of allergic diseases | |
| FI973173A0 (en) | Process for the treatment of condensate | |
| FI973644A (en) | New process for the preparation of 2,3-dihydrobenzofuranol derivatives | |
| DK0815092T3 (en) | Process for the preparation of 1,2-benzisothiazolin-3-ones | |
| NO985535D0 (en) | Process for the preparation of 1,3-alkanediols | |
| NO973366D0 (en) | Procedure for the treatment of multiple sclerosis | |
| NO960307D0 (en) | Process for the preparation of substituted 4,6-diamino-5-cyanopyrimidines | |
| NO179101C (en) | Process for the preparation of diblocked 2,3-hydroxymethylcyclobutanol | |
| FI964829A (en) | Process for the preparation of 2,2,4-trimethyl-1,3-pentanediolisobutyrate | |
| HK1010095A1 (en) | Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals. | |
| EP0579077A3 (en) | 1,3,4-thiadiazinones for the treatment of cardiovascular diseases | |
| DK0783491T3 (en) | Process for the preparation of 3,3,5-trichloro-glutarimide | |
| NO962812D0 (en) | Procedure for the treatment of pneumonia | |
| FI954263A0 (en) | For the purposes of this Regulation, the application was made | |
| FI951660A0 (en) | For the purposes of this Regulation | |
| FI954795A0 (en) | For the purposes of this Regulation | |
| RU95117268A (en) | MEANS FOR TREATMENT OF ATOPIC DERMATITIS | |
| FI940088A0 (en) | Regulation / Regulation For the purposes of this Regulation, the provisions of this Regulation shall apply | |
| DK0737068T3 (en) | 2,3-diaryl-1-benzopyrans for the treatment of dermatitis |